Phytolon Raises $23.6M to Launch Yeast-Derived Beetroot Red Dye for Food

Why It Matters

The capital infusion accelerates commercialization of a natural, cost‑effective dye just as the FDA’s ban on Red 3 and label reforms push manufacturers toward clean‑label ingredients, reshaping the food‑colour market.

Key Takeaways

• Phytolon secured $23.6M Series B to commercialize beetroot red dye.
• FDA approved beetroot red, enabling “no artificial colors” label claims.
• Yeast‑based fermentation cuts cost and carbon footprint versus synthetic dyes.
• Major CPGs are reformulating, driven by consumer and regulatory pressure.

Pulse Analysis

The natural‑colour market is entering a tipping point as regulators tighten rules on synthetic pigments and consumers demand cleaner labels. The FDA’s recent amendment recognizing beetroot‑derived betanin as safe, coupled with its upcoming ban on Red 3, creates a regulatory vacuum that precision‑fermented alternatives can fill. Industry analysts estimate that artificial dyes appear in roughly 20 % of packaged foods in the United States, a segment ripe for disruption by cost‑competitive, plant‑based substitutes.

Phytolon leverages baker’s yeast engineered to express betanin through controlled fermentation, then removes the organism to deliver a pure, heat‑ and pH‑stable colour in both liquid and powder forms. This biomanufacturing route offers several advantages: lower production costs at scale, reduced reliance on petroleum‑derived feedstocks, and a smaller carbon footprint compared with traditional chemical synthesis. By offering a versatile palette that spans red, orange, pink, yellow and purple, the company positions itself to serve bakery, dairy, confectionery and frozen‑food applications, expanding beyond its initial red focus.

The $23.6 million raise places Phytolon among a wave of well‑funded colour innovators, including Chromologics, Octarine Bio and Cambridge spin‑out Sparxell. As major food groups like Nestlé, Mars and General Mills accelerate reformulations, the demand pipeline for natural pigments is expected to surge. Phytolon’s strategic investor network and FDA‑cleared product give it a first‑mover edge, but scaling production and winning shelf‑space will be critical. If the company can meet commercial volumes while maintaining price parity, it could capture a significant share of the $1.5 billion U.S. food‑colour market within the next few years.